Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tumor-infiltrating CD39+CD8+ T cells determine poor prognosis and immune evasion in clear cell renal cell carcinoma patients
Qi Yu, Yu Xia, Zhiyuan Lin, et al.
Cancer Immunology Immunotherapy (2020) Vol. 69, Iss. 8, pp. 1565-1576
Open Access | Times Cited: 95

Showing 1-25 of 95 citing articles:

Mapping the immune environment in clear cell renal carcinoma by single-cell genomics
Nicholas Borcherding, Ajaykumar Vishwakarma, Andrew P. Voigt, et al.
Communications Biology (2021) Vol. 4, Iss. 1
Open Access | Times Cited: 244
ATP and cancer immunosurveillance
Oliver Kepp, Lucillia Bezu, Takahiro Yamazaki, et al.
The EMBO Journal (2021) Vol. 40, Iss. 13
Open Access | Times Cited: 157
Intratumoral CXCL13+CD8+T cell infiltration determines poor clinical outcomes and immunoevasive contexture in patients with clear cell renal cell carcinoma
Siyuan Dai, Han Zeng, Zhaopei Liu, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 2, pp. e001823-e001823
Open Access | Times Cited: 149
CD39 Regulation and Functions in T Cells
Eleonora Timperi, Vincenzo Barnaba
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 8068-8068
Open Access | Times Cited: 111
Derivation of prognostic contextual histopathological features from whole-slide images of tumours via graph deep learning
Yong‐Ju Lee, Jeong Hwan Park, Sohee Oh, et al.
Nature Biomedical Engineering (2022)
Closed Access | Times Cited: 78
Clear Cell Renal Cell Carcinoma: From Biology to Treatment
Adam M. Kase, Daniel J. George, Sundhar Ramalingam
Cancers (2023) Vol. 15, Iss. 3, pp. 665-665
Open Access | Times Cited: 49
Inosine induces stemness features in CAR-T cells and enhances potency
Dorota D. Klysz, Carley Fowler, Meena Malipatlolla, et al.
Cancer Cell (2024) Vol. 42, Iss. 2, pp. 266-282.e8
Open Access | Times Cited: 44
Updates on Immunotherapy and Immune Landscape in Renal Clear Cell Carcinoma
Myung‐Chul Kim, Jin Zeng, Ryan Kolb, et al.
Cancers (2021) Vol. 13, Iss. 22, pp. 5856-5856
Open Access | Times Cited: 59
CD39 + tissue-resident memory CD8 + T cells with a clonal overlap across compartments mediate antitumor immunity in breast cancer
Yong Joon Lee, Jee Ye Kim, Seung Hyuck Jeon, et al.
Science Immunology (2022) Vol. 7, Iss. 74
Closed Access | Times Cited: 42
Review immune response of targeting CD39 in cancer
Yao Liu, Zhongliang Li, Xiaoguang Zhao, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 24
PD1/PD-L1 blockade in clear cell renal cell carcinoma: mechanistic insights, clinical efficacy, and future perspectives
Zhu Zhao-yang, Yigang Jin, Jing Zhou, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 9
Targeting adenosine and regulatory T cells in cancer immunotherapy
Alexey V. Churov, Г. А. Жулай
Human Immunology (2021) Vol. 82, Iss. 4, pp. 270-278
Closed Access | Times Cited: 46
Treatment of adult ALL patients with third-generation CD19-directed CAR T cells: results of a pivotal trial
Maria‐Luisa Schubert, Anita Schmitt, Angela Hückelhoven‐Krauss, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 20
An integrative multi-omics analysis based on disulfidptosis-related prognostic signature and distinct subtypes of clear cell renal cell carcinoma
Dong Zhang, Xi Zhang, Zhanpeng Liu, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 17
Identification of clinically relevant subsets CD39+PD-1+CD8+ T cells and CD39+ regulatory T cells in intrahepatic cholangiocarcinoma using single-cell CyTOF
Qiwei Zhang, Mengxuan Zhu, Wenfeng Liu, et al.
Translational Oncology (2024) Vol. 44, pp. 101954-101954
Open Access | Times Cited: 6
Plasma CD27, a Surrogate of the Intratumoral CD27–CD70 Interaction, Correlates with Immunotherapy Resistance in Renal Cell Carcinoma
Nadine Benhamouda, Ikuan Sam, Nicolas Epaillard, et al.
Clinical Cancer Research (2022) Vol. 28, Iss. 22, pp. 4983-4994
Open Access | Times Cited: 25
Hypoxia-Regulated Tumor-Derived Exosomes and Tumor Progression: A Focus on Immune Evasion
Xuejun Shao, Shenghao Hua, Tao Feng, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11789-11789
Open Access | Times Cited: 25
Causal role of immune cells in thyroid cancer: a two-sample Mendelian randomization study
Shurong Wang, Zhouyu Fang, Wenjin Xiao, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Tumor-infiltrating TNFRSF9 + CD8 + T cells define different subsets of clear cell renal cell carcinoma with prognosis and immunotherapeutic response
Yaohui Li, Zewei Wang, Wenbin Jiang, et al.
OncoImmunology (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 37
Identification of the Prognosis Value and Potential Mechanism of Immune Checkpoints in Renal Clear Cell Carcinoma Microenvironment
Guodong Liao, Ping Wang, Yuyong Wang
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 31
Multiplexed single-cell pathology reveals the association of CD8 T-cell heterogeneity with prognostic outcomes in renal cell carcinoma
Tetsushi Murakami, Nobuyuki Tanaka, Kimiharu Takamatsu, et al.
Cancer Immunology Immunotherapy (2021) Vol. 70, Iss. 10, pp. 3001-3013
Closed Access | Times Cited: 28
Development and validation of ferroptosis-related lncRNAs prognosis signatures in kidney renal clear cell carcinoma
Xiao‐Liang Xing, Zhi-Yong Yao, Jialan Ou, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 27
The value of erlotinib related target molecules in kidney renal cell carcinoma via bioinformatics analysis
YunQiang Zhang, Mingyang Tang, Qiang Guo, et al.
Gene (2022) Vol. 816, pp. 146173-146173
Closed Access | Times Cited: 19
Landscape of adenosine pathway and immune checkpoint dual blockade in NSCLC: progress in basic research and clinical application
Ru-Lan Wang, Zhenkun Liu, Ting Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Immune cell signatures and inflammatory mediators: unraveling their genetic impact on chronic kidney disease through Mendelian randomization
Yongzheng Hu, Fengyun Hao, Qian An, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top